Association of Serum Lipids, Oxidative Stress and serum Cystatin C with Prehypertension and Hypertension
Abstract
Introduction: Hypertension is the most important cardio vascular risk factor, contributing to one half of the coronary heart diseases and approximately two third of the cerebrovascular diseases. Hypertension has been recognised as one of ten (10) leading reported causes of death with about 4% of such deaths due to hypertensive complications. Cystatin C is independently and positively associated with the risk for hypertension. There is a mounting body of evidence which indicates reactive oxygen species (ROS) production is linked to vascular/endothelial dysfunction.With this background we assessed lipids, oxidative stress and cystatin C in serum of patients with essential hypertension and prehypertension.
Materials and methods: Total cholesterol, Triglyceride, HDL cholesterol, LDL cholesterol, Malondialdehyde (MDA), Total antioxidant capacity (TAC) and cystatin C were measured in serum of subjects with essential hypertension, prehypertension and age and sex matched controls. Study groups comprised of 66 each, subjects with hypertension and prehypertension. Control group comprised of 68 healthy volunteers.
Results: Mean serum levels of MDA, Cholesterol, Triglycerides and LDL cholesterol and cystatin C were significantly increased and TAC and HDL cholesterol levels were significantly decreased in subjects with hypertension and prehypertension compared to controls.
Conclusion: Our results revealed that both hypertension and prehypertension are associated with dyslipidemia, altered oxidative status and raised serum cystatin C levels. Our study also suggests the continued need for early clinical detection and intervention of prehypertension to reduce adverse health consequences of hypertension and its impact.
Downloads
References
2. Classification of hypertension. Report of WHO Scientific Group, WHO Technical Report Series 1978; 657: 87-95(s)
3. Kearney, P., Whelton, M., Reynolds, K., Muntner, P., Whelton, P., & He, J. (2005). Global burden of hypertension: analysis of worldwide data. Lancet, 365 (9455), 217-223. [PubMed]
4.WHO.A global brief on hypertension- Silent killer, global public health crisis .April 2013. (http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/)
5. Theodore A.Kotchen,. Harrison's Principles of Internal Medicine . 17th ed .New York : McGraw-Hill; 2008. Chapter 241, Hypertensive Vascular Disease ; p.1549-62.
6. The seventh Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) ,Aug 2004.( http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf)
7. Gordon H, Eugene Braunwald et.al. Harrison’s Principles of Internal Medicine .15th edition; New York :McGraw--Hill 2000; . Hypertensive vascular disease; p. 141-1430.
8. Redon J., Oliva M.R., Tormos C., et alAntioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003 ; 41:1096–1101. [PubMed]
9. Parikh NI, Hwang SJ, Yang Q, Larson MG, Guo CY, Robins SJ, et al. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008;102:1194-1198. [PubMed]
10. B.A.Bhavani, T.Padma, B.K.S.Sastry. Plasma Lipoprotein (a) levels in patients with untreated essential hypertension .Indian Journal of Human Genetics : 2003; 9( 2) : 65-68.
11. Biswas UK And Kumar A Study On Lipid Profile, Oxidation Stress And Carbonic Anhydrase Activity In Patients With Essential Hypertension. Journal of Clinical and Diagnostic Research ;2010 December 10; (4):3414-3420. [PubMed]
12. Alderman MH, Ooi WL, Cohen H, Madhavan S, Sealey JE, Laragh JH. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens 1997;10(1):1-8. [PubMed]
13. Uehara Y, Urata H, Sasaguri M et al. Increased chymase activity in internal thoracic artery of patients with hypercholesterolaemia. Hypertension 2000;35:55-60. [PubMed]
14. Ferrario CM. Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview. Drugs 1990;39(suppl 2):1-8. [PubMed]
15. Schiffrin EL. State-of-the-art lecture. Role of endothelin-1 in hypertension. Hypertension 1999;34:876-81. [PubMed]
16. Ramón Rodrigo, HernánPrat, Walter Passalacqua.Relationship between oxidative stress and essential hypertension.Hypertension research official journal of the Japanese Society of Hypertension 2007;30(12):1159-1167.
17. Russo.C,OlivieriO,Girelli D Anti-oxidant status and lipid peroxidation in patients with essential hypertension.J Hypertens. 1998 Sep;16(9):1267-71. [PubMed]
18. RuiTang, Hai-taoLi,Wen-jun Ma and Shao-xianSun. Serum lipid peroxidation levels in prehypertensive patients. American Journal of Hypertension 2010; 23(1):104.
19. Xu, S., &Touyz, R. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can. J. Cardiol. 2006; 947-951. [PubMed]
20. Kristal, B., Shurta-Swirrki, R., &Chezar, J. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patient with essential hypertension. Hypertension, 1998; 921-928.
21. Minuz, P., Fava, C., &Lechi, A. Lipid peroxidation, isoprostanes and vascular damage. Pharma. Reports, 2006;57-68. [PubMed]
22. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104:1191-1197. [PubMed]
23. Shankar A, Teppala. S Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney disease. J Am Soc Hypertens. 2011 Sep-Oct;5(5):378-84. [PubMed]
24. Bryan Kestenbaum, Kyle D. Rudser .Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis. Ann Intern Med April 1, 2008; 148:501-508. [PubMed]
24. Kestenbaum B, Rudser KD, de Boer IH, Peralta CA, Fried LF, Shlipak MG, Palmas W, Stehman-Breen C, Siscovick DS. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med. 2008 Apr 1;148(7):501-8.
OAI - Open Archives Initiative
